Couples Dynamics and Smoking Cessation (SCOR)

April 18, 2023 updated by: Matthew Kirkpatrick, University of Southern California

Interpersonal Mechanisms of Smoking Relapse in Romantic Couples

This study is about investigating smoking and attempts to quit smoking in couples. Participation will help determine better treatment efforts for couples who want to quit smoking. All study procedures will be conducted remotely, allowing couples to interact with study personnel through zoom.

Study Overview

Study Type

Observational

Enrollment (Actual)

212

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Los Angeles, California, United States, 90033
        • University of Southern California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants may live through the United States.

Description

Inclusion Criteria:

  • Couples must be in a relationship for more than 6 months with no plans to separate or move in the next 30 days.
  • Participants must smoke at least 5 cigarettes per day for at least the past 2 years.

Exclusion Criteria:

  • English non-fluency.
  • Currently pregnant, nursing, or intend to become pregnant within the next 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Both-Quit Group
Couples in which both individuals smoke and both individuals would like to quit smoking.
There are no interventions in this study. Participants are observed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cigarette Craving
Time Frame: Throughout study completion, an average of 28 days
This measure is obtained through the completion of the Brief Questionnaire of Smoking Urges.
Throughout study completion, an average of 28 days
Confidence in Quit Attempt
Time Frame: Throughout study completion, an average of 28 days
This measure is obtained through the completion of the Abstinence Self-Efficacy Questionnaire.
Throughout study completion, an average of 28 days
Mood
Time Frame: Throughout study completion, an average of 28 days
This measure is obtained through the completion of the Profile of Mood States Questionnaire.
Throughout study completion, an average of 28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew Kirkpatrick, PhD, University of Southern California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 26, 2018

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

March 6, 2019

First Submitted That Met QC Criteria

March 19, 2019

First Posted (Actual)

March 21, 2019

Study Record Updates

Last Update Posted (Actual)

April 20, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HS-16-00898

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on No Interventions

3
Subscribe